T. Rowe Price Associates’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Buy |
59,428
+5,499
| +10% | +$12.1K | ﹤0.01% | 2838 |
|
|
2025
Q1 | $117K | Sell |
53,929
-790,894
| -94% | -$1.72M | ﹤0.01% | 2787 |
|
|
2024
Q4 | $3.58M | Buy |
844,823
+36,319
| +4% | +$154K | ﹤0.01% | 1386 |
|
|
2024
Q3 | $9.25M | Buy |
808,504
+162,672
| +25% | +$1.86M | ﹤0.01% | 1150 |
|
|
2024
Q2 | $6.9M | Buy |
645,832
+8,228
| +1% | +$88K | ﹤0.01% | 1167 |
|
|
2024
Q1 | $9.79M | Buy |
+637,604
| New | +$9.79M | ﹤0.01% | 1113 |
|